Study Summary
This trial sought to compare the efficacy of transepithelial CXL with conventional CXL in the treatment of progressive keratoconus.
- Keratoconus
- Corneal Ectasia
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 1 year
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Riboflavin drop every 10 minutes
1 of 2
Riboflavin drop every 2 minutes
1 of 2
Active Control
160 Total Participants · 2 Treatment Groups
Primary Treatment: Riboflavin drop every 10 minutes · No Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age Any Age · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Did the FDA approve Riboflavin to be used every 10 minutes?
"This medication has been shown to be effective in prior clinical trials and has received multiple rounds of safety testing, so it received a score of 3." - Anonymous Online Contributor
What illness does Riboflavin drop every 10 minutes commonly help cure?
"Riboflavin, administered through drops every ten minutes, is often used to treat nutritional deficiencies. This vitamin can also ameliorate joint pain and be used as part of a general vitamin supplement routine." - Anonymous Online Contributor
Are there any other scientific investigations involving a similar Riboflavin dosing schedule?
"At the moment, there are 20 ongoing clinical trials for Riboflavin drop every 10 minutes. 11 of these studies are in Phase 3. Although most of the research for Riboflavin drop every 10 minutes is being conducted in San Francisco, there are a total of 47 research sites for this treatment." - Anonymous Online Contributor